Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05968300 · ClinicalTrials.gov registry record · NA

Getting INFORMED and Living Well Among Asian Americans in California

A NA study of COVID-19 and Well-Being, Psychological, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
616
Enrollment target
4
Study locations

NCT05968300 is a NA study of COVID-19 and Well-Being, Psychological that has completed, run by University of California, San Francisco. The registered enrollment target is 616 participants, below the 55,211-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05968300, a NA study of COVID-19 and Well-Being, Psychological, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
616 participants
Enrollment target
4
Study locations

Study Summary

The project is to facilitate pandemic recovery by promoting emotional wellness among Asian Californians. The intervention includes a 6-week program in which participants may choose to receive text only or text + Lay Health Worker outreach targeting 600 self-identified Asian Americans residing in California who speak/read English, Chinese, Korean, Hmong, or Vietnamese.

Interventions

  • BEHAVIORAL Text Messaging Only
  • BEHAVIORAL INFORMED-Living Well

Study Locations (4)

California

  • The Fresno Center - Fresno
  • Chinese Community Health Resource Center - San Francisco
  • University of California, San Francisco - San Francisco
  • Immigrant Resettlement & Cultural Center - San Jose

Trial Details

FieldValue
Enrollment Target 616 participants
Start Date 2024-03-20
Est. Completion 2024-08-31
Phase NA

What the Registry Record Tells You About NCT05968300

The ClinicalTrials.gov registry entry for NCT05968300 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 616 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,211-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which Text Messaging Only is the first listed.

NCT05968300 reports 4 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05968300 about?

NCT05968300 is a clinical study titled "Getting INFORMED and Living Well Among Asian Americans in California". The project is to facilitate pandemic recovery by promoting emotional wellness among Asian Californians. The intervention includes a 6-week program in which participants may choose to receive text only or text + Lay Health Worker outreach targeting 600 self-identified Asian Americans residing in Cal...

What is the current status of trial NCT05968300?

This trial is currently completed. It is a NA study. The enrollment target is 616 participants. The study started on 2024-03-20. Estimated completion is 2024-08-31.

What conditions does trial NCT05968300 study?

This clinical trial studies the following conditions: COVID-19, Well-Being, Psychological.

What interventions are being tested in trial NCT05968300?

The interventions under investigation include: Text Messaging Only (BEHAVIORAL), INFORMED-Living Well (BEHAVIORAL).

Who is sponsoring clinical trial NCT05968300?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05968300 being conducted?

This trial has 4 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.